ICGEB Governors meet in Trieste on 10-11 May 2018


The annual meeting of the Board reached a record of participation in Trieste, with over 100 delegates from 50 countries presiding: a clear indication of the worldwide interest in the activities of the Centre.

The session was opened by the President of the Board, Victor Smirnov of the Russian Federation, Mr. Philippe Scholtés, Managing Director of UNIDO, Vienna, Fabrizio Nicoletti, Head, Bilateral and Multilateral Scientific and Technological Cooperation Unit, DG for the Promotion of the Country System, Italian Ministry of Foreign Affairs and Mauro Giacca, ICGEB Director-General, with guest speaker, Prof. Stefano Fantoni illustrating ESOF2020: Trieste European City of Science.

Breaking news from the Board included the presentations of the new Regional Research Centres (RRCs) of the ICGEB: to be located in the China Medical City science park, Taizhou,China (the park already comprises more than 800 companies working in the biomedical sector, including the subsidiaries of several large multinational pharmaceutical companies), where ICGEB will be the catalyst for research in the field of innovative pharmaceutical therapies for cancer and degenerative diseases. The second, in Panama City, also located within a new science park, INDACASAT AIP, supported by the Panamanian Government thanks to income originating from the Panama Canal and where research will focus on the use of molecules deriving from natural resources of the country to develop new pharmaceuticals against infectious and degenerative diseases.

Other developments included the presentation of the advancing proposal for an RRC in Sri Lanka, membership in the ICGEB by Zimbabwe and the renewed expression of interest by Brazil to explore an RRC proposal.

During the Board a collaboration Agreement between the ICGEB and EU JRC was signed by the DG and Elke Anklam, Director, Health Consumers and Reference Materials of the Joint Research Centre (JRC), European Science Hub, the largest research institute, of the European Commission. Under this Agreement, the ICGEB and the JRC will develop communal projects applying biotechnology in medicine and agriculture, with a view to harmonising the use of biotechnologies in Europe and Africa.

The Director-General announced his intention not to request renewal of his mandate beyond 2019, in order to dedicate activity exclusively to the pursuit of his scientific research. He will leave ICGEB for an academic posting at the School of Cardiovascular Medicine, King’s College London, UK, where he will head a research team on the development of novel therapies for infarction and cardiovascular disease. The Board expressed great appreciation for his work and the wish that his association with the ICGEB continue, albeit in a different capacity. The Board has activated the procedure, on an international scale, to seek a new Director General for the organisation for the next five year term: 2019-2024.

#ICGEBBoard24 on Twitter and Facebook

23 May 2018

Press Release

 

tl_files/hq/BoG 2018/2018 Board of Governors photoRED.jpg

 

24 May 2018

Audio statement by Mr. Philippe Scholtès, Managing Director, UNIDO Vienna at the ICGEB Press Conference

tl_files/hq/BoG 2018/Scholtes.jpg

 

Further Reading:

June 2018 (in Chinese)
Taizhou Municipal Government

Taizhou Daily

Jiangsu Provincial Committee of the Communist Party of China

China National Center for Biotechnology Development

Go back

Cod. Fisc. 90031700322

AREA Science Park
Padriciano 99
34149 Trieste, ITALY
Tel: +39-040-37571
Fax: +39-040-226555
icgebicgeb.org
Address book

 

 

 tl_files/iTunes_Badge_Color_master_10251024.png

 

tl_files/FB.png tl_files/Twitter_logo_blue-1def.png tl_files/rss.png
tl_files/InstagramICGEB_gray.png tl_files/LinkedIn-InBug-2CRev2.png tl_files/YouTube.png 

 

tl_files/News 2017/INTERREG/INTERREG_IT-SLO_FUND_RGB.jpg